Showing 19,901 - 19,920 results of 99,250 for search '(( 5 ht decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.56s Refine Results
  1. 19901

    Cell Type Specific Alterations in Interchromosomal Networks across the Cell Cycle by Andrew J. Fritz (638393)

    Published 2014
    “…These alterations in interaction profiles were subdivided into five types: overall increase, overall decrease, switching from 1 to ≥2 interactions, vice versa, or no change. …”
  2. 19902
  3. 19903

    Differential binding of the AKR and DBA variants of ARID4B to the mSIN3A complex. by Scott F. Winter (160645)

    Published 2012
    “…<p>Western blots (A) show equivalent input of V5-ARID4B, mSIN3A, mSDS3, and equivalent pull-down of the two variants using an anti-V5 antibody. …”
  4. 19904

    Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last? by Aygul Tantik PAK (12686251)

    Published 2022
    “…In the third month, it was 5.85±2.59 tablets/month (p<0.001). There was a significant increase in pain medication use from the second to the third month (p<0.001). …”
  5. 19905

    Impact evaluation of Zika epidemic on congenital anomalies registration in Brazil: An interrupted time series analysis by Enny S. Paixão (7419110)

    Published 2019
    “…We found that immediately after the interruption point, there was a great increase in the notification rate of congenital anomalies of 14.9/10,000 live births in the brain and eye group and of 5.2/10,000 live births in the group not related with brain or eye malformations. …”
  6. 19906
  7. 19907

    DataSheet_1_Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study.docx by Hailun Xie (10278446)

    Published 2024
    “…Logistic regression analysis revealed that patients with low ApoA-I had a 32.5% increased risk of disease recurrence (odds ratio [OR] 0.675; 95%CI, 0.481–0.946; P = 0.0225) compared with those with high ApoA-I. …”
  8. 19908

    DataSheet_1_Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study.docx by Hailun Xie (10278446)

    Published 2024
    “…Logistic regression analysis revealed that patients with low ApoA-I had a 32.5% increased risk of disease recurrence (odds ratio [OR] 0.675; 95%CI, 0.481–0.946; P = 0.0225) compared with those with high ApoA-I. …”
  9. 19909
  10. 19910
  11. 19911
  12. 19912
  13. 19913
  14. 19914

    Genome-wide regulation of electro-acupuncture on the neural <i>Stat</i>5-loss-induced obese mice - Fig 4 by Shu-Ping Fu (549948)

    Published 2017
    “…(A) Overlapping area represents upregulated gene number (310) in the <i>Stat</i>5NKO group (<i>vs</i>. the <i>Stat</i>5fl/fl group) but decreased in the EA group; (B) The heatmap was created using the FPKM values of the 310 overlapping genes in 5A; (C) Pathway analysis of the 310 overlapping genes in 5A. …”
  15. 19915

    Nuclear proteome profiling in A549 cells after DOX and/or LMB treatment. by Chuanwen Lu (159114)

    Published 2012
    “…Approximately 1,000 protein spots were detected in nuclear extractions of A549 cells. Spots labeled with red color indicate decreased expression after LMB treatment, while spots labeled with green color indicate increased expression after LMB treatment (left panel). …”
  16. 19916

    Raw data of Figs 1–6 in this study. by Qi Qi Lu (17721401)

    Published 2025
    “…Additionally, larval invasion of Caco-2 monolayer was also decreased by siPGAM5 and inhibitor pretreatment. These findings indicated that inhibition of PGAM5 receptor and apoptosis prevented rTsSPc from damaging gut epithelial integrity and larval invasion.…”
  17. 19917

    Metabolite profile of benzoic acid biotransformation with hippuric acid as outcome. by Cindy Irwin (3373793)

    Published 2016
    “…Enzyme nomenclature (names accepted by the IUBMB): EC 1.4.1.2: glutamate dehydrogenase; EC 2.1.1.2: guanidinoacetate N-methyltransferase; EC 2.1.2.1: glycine hydroxymethyltransferase (alt.: serine hydroxymethyltransferase); EC 2.1.2.10: aminomethyltransferase (a glycine synthetase); EC 2.1.3.3: ornithine carbamoyltransferase; EC 2.1.4.1: glycine amidinotransferase; EC 2.3.1.1: amino-acid N-acetyltransferase; EC 2.3.1.71: glycine N-benzoyltransferase (a GLYAT); EC 2.7.3.2: creatine kinase; EC 3.5.3.1: arginase; EC 4.3.2.1: argininosuccinate lyase; EC 6.2.1.2: butyrate-CoA ligase (a medium-chain acyl-CoA ligase); EC 6.3.4.5: argininosuccinate synthase; EC 6.3.5.5: carbamoyl-phosphate synthase (glutamine-hydrolyzing)</p>…”
  18. 19918
  19. 19919
  20. 19920